IL6 and type 2 diabetes mellitus: IL-1β, a major pro-inflammatory cytokine, is critically involved in INS signaling alterations; in obese individuals, high IL-1β and IL-6 circulating levels represent an important independent risk for developing type 2 diabetes [46].